Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2026 ▲▼ | Q2 2026 ▲▼ | Change ▲▼ | Q1 2026 ▲▼ | Q2 2026 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Kailera Therapeutics Inc | 0 | 22,583,268 | +22,583,268 | $0 | $497.51M | 29.58% | +$497.51M |
| Heartflow, Inc.(HTFL) | 10,448,158 | 8,448,158 | -2,000,000 | $254.20M | $247.87M | 14.74% | -$6.33M |
| Newamsterdam Pharma Company ORDINARY SHARES | 7,306,566 | 3,806,566 | -3,500,000 | $233.88M | $129.00M | 7.67% | -$104.88M |
| Savara Inc.(SVRA) | 17,600,621 | 17,600,621 | 0 | $96.10M | $108.42M | 6.45% | +$12.32M |
| Alkermes plcSHS(ALKS) | 610,000 | 1,937,938 | +1,327,938 | $21.57M | $101.54M | 6.04% | +$79.97M |
| Solid Biosciences Inc | 9,808,819 | 9,808,819 | 0 | $70.62M | $97.99M | 5.83% | +$27.37M |
| Pharvaris N V COM | 2,675,509 | 2,675,509 | 0 | $75.58M | $92.52M | 5.50% | +$16.94M |
| Olema Pharmaceuticals, Inc.(OLMA) | 7,473,238 | 7,085,249 | -387,989 | $111.43M | $88.64M | 5.27% | -$22.79M |
| Hemab Therapeutics Holdings Inc | 0 | 1,650,000 | +1,650,000 | $0 | $60.60M | 3.60% | +$60.60M |
| Cabaletta Bio, Inc.(CABA) | 9,677,125 | 17,241,445 | +7,564,320 | $26.03M | $53.62M | 3.19% | +$27.59M |
| X4 Pharmaceuticals, Inc.(XFOR) | 7,967,454 | 7,967,454 | 0 | $32.91M | $37.21M | 2.21% | +$4.30M |
| Dianthus Therapeutics, Inc.(DNTH) | 362,470 | 362,470 | 0 | $30.42M | $35.33M | 2.10% | +$4.92M |
| C4 Therapeutics, Inc.(CCCC) | 7,171,910 | 7,171,910 | 0 | $18.86M | $33.49M | 1.99% | +$14.63M |
| Kyverna Therapeutics, Inc.(KYTX) | 3,110,000 | 2,885,000 | -225,000 | $26.84M | $25.71M | 1.53% | -$1.13M |
| Annexon, Inc.(ANNX) | 5,212,674 | 4,437,731 | -774,943 | $28.88M | $25.34M | 1.51% | -$3.54M |
| Rapid Micro Biosystems, Inc.CL A(RPID) | 8,434,560 | 8,434,560 | 0 | $19.15M | $14.59M | 0.87% | -$4.55M |
| Disc Medicine, Inc.(IRON) | 141,234 | 141,234 | 0 | $9.03M | $10.33M | 0.61% | +$1.30M |
| Atea Pharmaceuticals, Inc.(AVIR) | 2,360,638 | 2,075,639 | -284,999 | $12.70M | $9.65M | 0.57% | -$3.05M |
| Xilio Therapeutics, Inc.(XLO) | 664,021 | 664,021 | 0 | $5.58M | $6.36M | 0.38% | +$776.9K |
| Upstream Bio, Inc.(UPB) | 867,211 | 600,949 | -266,262 | $7.80M | $4.16M | 0.25% | -$3.65M |
| Newamsterdam Pharma CompanyW EXP 99 99 999 *W EXP 99/99/999 | 99,999 | 99,999 | 0 | $2.00M | $2.14M | 0.13% | +$133.0K |
| Centessa PharmaceuticalsADS | 635,000 | 0 | -635,000 | $25.22M | $0 | — | -$25.22M |